Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of complement-associated disorders

Treatment of complement-associated disorders

US Patent 7419663 · Granted Sep 2, 2008

Estimated economic value: $414,196,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method to use gene expression to determine likelihood of clinical outcome of ren2025
Method to use gene expression to determine likelihood of clinical outcome of ren2023
Gene expression profile algorithm for calculating a recurrence score for a patie2023
VEGF/DLL4 binding agents and uses thereof2022
Anti-FGFR3 antibodies and methods using same2022
Combination therapy for treatment of disease2021
Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related d2021
Method to use gene expression to determine likelihood of clinical outcome of ren2021
VEGF/DLL4 binding agents and uses thereof2020
TIGIT-binding agents and uses thereof2020
Anti-FGFR3 antibodies and methods using same2019
Method for using gene expression to determine prognosis of prostate cancer2019